CRL · 8-K · 20260805PR000115

Geographic Market Commentary

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 25 · Surprise 32

Research Models and Services (RMS) organic revenue declined 1.4%, primarily because of lower small research model revenue in North America and lower research model services revenue. The North American weakness was partially offset by higher small research model revenue in China. Charles River also said the DSA demand improvement was broad based across its global biopharmaceutical and small and mid-sized biotechnology customer base.